Danahy Kevin Patrick 的 Form 4 申報
Pulse Biosciences, Inc.（PLSE），2026/2/11 申報
- 申報編號
- 0001437749-26-003840
- 申報時間
- 2026/2/11
- 交易日
- 2026/2/9-2/11
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 6 筆非衍生性交易、3 筆衍生性交易。公開市場賣出合計 $140.3 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Danahy Kevin PatrickCIK 0001913245 | 高階主管（商務長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/2/9 | Common Stock | M行使選擇權取得 | +20,000 | $1.53 | +$30,600 | 63,298 | 直接 | |
| 2026/2/9 | Common Stock | S賣出處分 | −20,000 | $21.45F2 | −$429,000 | 43,298 | 直接 | |
| 2026/2/10 | Common Stock | M行使選擇權取得 | +20,000 | $1.53 | +$30,600 | 63,298 | 直接 | |
| 2026/2/10 | Common Stock | S賣出處分 | −20,000 | $23.52F3 | −$470,400 | 43,298 | 直接 | |
| 2026/2/11 | Common Stock | M行使選擇權取得 | +20,000 | $1.53 | +$30,600 | 63,298 | 直接 | |
| 2026/2/11 | Common Stock | S賣出處分 | −20,000 | $25.20F4 | −$504,000 | 43,298 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/2/9 | Common Stock | M行使選擇權處分 | −20,000 | $0.00 | $0 | 405,000 | 直接 | |
| 2026/2/10 | Common Stock | M行使選擇權處分 | −20,000 | $0.00 | $0 | 385,000 | 直接 | |
| 2026/2/11 | Common Stock | M行使選擇權處分 | −20,000 | $0.00 | $0 | 365,000 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $21.00 to $23.22 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $23.00 to $26.08 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $23.36 to $26.36 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range.
表 I 有 1 筆交易的價格引用這則附註。